Promote Sponsor
verified SJR 4,936 · Q1 • database Scopus / SJR & Web of Science indexed
The Lancet Haematology
United Kingdom · Elsevier Ltd
workspace_premium Q1 — Hematology lock Subscription Unclaimed

The Lancet Haematology

The Lancet Haematology is a journal indexed in SJR in Hematology with an H index of 103. It has an SJR impact factor of 4,936 and it has a best quartile of Q1. It has an SJR impact factor of 4,936.

The Lancet Haematology focuses its scope in these topics and keywords: duration, cohort, rituximab, shortened, treatment, syndrome, standard, lymphoma, prevention, therapy, ...

Editorial: Elsevier Ltd
Category: Hematology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
4,936 Q1
H-index 103
Tasa de Aceptación pie_chart
27% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

4,936

H-index

103

Docs (year)

192

Docs 3y

585

Total refs

3212

Cites 3y

3008

Citable 3y

258

Cites/Doc 2y

5.39

Ref/Doc

16.73

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQS